ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,430Medicare Part D Prescriptions Filled, Including Refills

Rank: 301 out of 5176

$1.1M Total Retail Price of All Prescriptions

Rank: 208 out of 5176

497 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 497 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 10,545 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

45% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
METOPROLOL TARTRATE 659 565 1 6
NEXIUM 619 504 2 16
CRESTOR 452 349 3 15
METFORMIN HCL 430 280 4 7
AMLODIPINE BESYLATE 426 337 5 2
HYDROCHLOROTHIAZIDE 412 300 6 10
FUROSEMIDE 362 333 7 8
SIMVASTATIN 362 278 7 1
ENALAPRIL MALEATE 339 278 9 22
PLAVIX 302 256 10 29
TAMSULOSIN HCL 283 227 11 20
ATORVASTATIN CALCIUM 278 226 12 9
LOVAZA 248 163 13 43
ZOLPIDEM TARTRATE 233 215 14 17
OMEPRAZOLE 232 191 15 3
LIPITOR 189 143 16 51
METOPROLOL SUCCINATE 176 145 17 11
LEVOTHYROXINE SODIUM 166 132 18 4
IBUPROFEN 161 124 19 72
GLYBURIDE 150 132 R 20 67
LISINOPRIL 141 84 21 5
DIOVAN 140 113 22 19
JANUVIA 126 92 23 25
MECLIZINE HCL 124 124 24 81
CLOPIDOGREL 118 102 25 26
CARVEDILOL 112 82 26 24
CREON 109 82 27 111
LABETALOL HCL 108 89 28 114
DEXILANT 104 97 29 118
CELEBREX 103 86 30 80
PRANDIN 102 88 31 150
WARFARIN SODIUM 100 72 32 13
GABAPENTIN 99 73 33 21
RAMIPRIL 99 66 33 50
SYNTHROID 95 60 35 33
LIDODERM 91 88 36 59
COLCRYS 88 61 37 170
LANSOPRAZOLE 87 80 38 113
TRAMADOL HCL 87 74 38 40
ALENDRONATE SODIUM 85 83 40 18
ADVAIR DISKUS 84 50 41 32
GLIPIZIDE 84 62 41 63
CLONIDINE HCL 76 72 43 79
HYDRALAZINE HCL 74 60 44 73
ATENOLOL 73 67 45 12
FAMOTIDINE 72 40 46 58
ZETIA 71 43 47 68
LANTUS SOLOSTAR 70 60 48 70
SPIRIVA 69 39 49 54
ESCITALOPRAM OXALATE 69 47 49 89
GLYBURIDE-METFORMIN HCL 67 64 R 51 76
LYRICA 62 47 52 133
LOSARTAN-HYDROCHLOROTHIAZIDE 62 50 52 35
SERTRALINE HCL 62 39 52 30
PANTOPRAZOLE SODIUM 57 46 55 61
ISOSORBIDE MONONITRATE ER 57 39 55 44
VENTOLIN HFA 57 36 55 64
SOLARAZE 56 42 58 157
VYTORIN 53 53 59 152
DILTIAZEM 24HR CD 53 53 59 119
HYDROCODONE-ACETAMINOPHEN 52 22 S3 61 27
NITROGLYCERIN PATCH 52 45 61 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.